FREE UK DELIVERY OVER £150 MADE TO ORDER THIRD-PARTY TESTED UK BASED SUPPORT EARN WITH APEXION PARTNERS

Apexion

Blog

Research notes, guides and Apexion updates.

KPV Peptide UK: What It Is, Research and Legal Status (2026)

KPV Peptide UK: What It Is, Research and Legal Status (2026)

Quick answer What is KPV peptide? KPV is a tripeptide (lysine-proline-valine) taken from the end of alpha-melanocyte-stimulating hormone (α-MSH). It’s studied mainly for its effect on inflammatory signalling in gut and skin cell models. UK law allows its purchase as research material. No regulator has licensed it as a medicine, and no controlled clinical trial…

Read more
Peptide stacks explained: a UK research guide

Peptide Stacks Explained: A UK Research Guide (2026)

Quick answer What is a peptide stack? A peptide stack is a combination of two or more peptides studied together, either as separate vials in one protocol or as a single pre-mixed blend. Researchers pair peptides that act on different pathways to study complementary mechanisms. Very few combinations have been tested as combinations, and none…

Read more
GHK-Cu UK: what it is, legal status and research

GHK-Cu UK: What It Is, Legal Status and Research (2026)

Quick answer What is GHK-Cu peptide? GHK-Cu (glycyl-L-histidyl-L-lysine copper) is a naturally occurring copper-binding tripeptide, originally isolated from human plasma. Scientists study it in collagen, wound-repair and gene-expression research. In the UK, topical GHK-Cu serums are sold as cosmetics. Research-grade GHK-Cu is a laboratory material, and neither one is a licensed medicine. For most of…

Read more
BPC-157 UK guide: what it is, legal status and research

BPC-157 UK: What It Is, Legal Status and Research (2026)

Quick answer What is BPC-157? BPC-157 (Body Protection Compound-157) is a synthetic 15-amino-acid peptide based on a fragment of a protein found in human gastric juice. Researchers have studied it mainly in animal and cell models of gut, tendon and blood-vessel biology. In the UK it’s legal to buy as a research material, though it…

Read more
LOW vs GLOW Peptide 2026: Key Differences & Which Is Better

KLOW vs GLOW Peptide Blend: Key Differences Compared

Quick answer What is the difference between KLOW and GLOW? GLOW is a 70mg three-peptide blend of GHK-Cu (50mg), BPC-157 (10mg) and TB-500 (10mg). KLOW is an 80mg four-peptide blend containing the same three compounds in the same amounts, plus 10mg of KPV. KPV is the only compositional difference, and it’s a tripeptide studied mainly…

Read more
Are Peptides Legal in the UK?

Are Peptides Legal in the UK? A 2026 Research Guide

Peptides spent much of 2026 in the headlines. The BBC ran a feature on the “wellness peptide craze” in March, and The Guardian followed in April by asking what the evidence says. One question got far less airtime than the science: are peptides legal in the UK, and who’s allowed to buy, sell or own…

Read more
Tesamorelin Research Overview: Mechanism & Classification

Tesamorelin Research Overview: Mechanism, Classification and Key Considerations

Quick answer Tesamorelin is a synthetic, stabilized analog of growth hormone-releasing hormone (GHRH) studied for its interaction with GHRH receptors on the pituitary gland. It has an approved clinical indication in some markets for a specific, narrow population, but we supply it strictly as a non-clinical research compound for laboratory use only. Contents Tesamorelin Research…

Read more
BPC-157 vs TB-500: Research Overview, Key Differences and Format Considerations

BPC-157 vs TB-500: Research Overview, Key Differences and Format Considerations

Contents Why BPC-157 and TB-500 Are Compared BPC-157 vs TB-500 is one of the most common peptide comparisons in research search results, yet the two are different materials with different scientific contexts. This guide is an educational comparison for laboratory and analytical research audiences. It is not guidance for human or veterinary administration, diagnosis, treatment,…

Read more
CJC-1295 vs Ipamorelin: Mechanisms & Why They're Studied Together

CJC-1295 vs Ipamorelin: Research Overview, Mechanisms and Why They’re Studied Together

Quick answer CJC-1295 is a growth hormone-releasing hormone (GHRH) receptor analog that supports sustained pituitary signaling, while Ipamorelin is a selective ghrelin receptor (GHSR-1a) agonist associated with pulsatile growth hormone release. They are frequently studied together because they act on distinct, complementary receptor pathways, which is why they work well together as a research pair.…

Read more
WhatsApp us